Researchers from The University of Texas MD Anderson Cancer Center, USA, presented encouraging findings today from…
Immunotherapy is already improving treatment options for many cancer types, but research groups keep exploring…
Chimeric antigen receptor T-cell therapy, or CAR T, has dramatically improved the treatment of certain…
Among available immunotherapies, the use of CAR-T cells is proving extremely effective against certain blood…
A single infusion of chimeric antigen receptor T-cell (CAR-T) therapy induced complete response or remission…
Prostate cancer frequently metastasizes to the bone and is incurable. Moffitt Cancer Center researchers are working to…
A new approach to chimeric antigen receptor T-cell (CAR T) therapy has shown great promise…
The CD70-targeting allogeneic chimeric antigen receptor (CAR) T cell therapy, ALLO-316, demonstrated encouraging response rates and…
During the 64th annual meeting of the American Society of Hematology (ASH), held December 10-13…
Mount Sinai and Memorial Sloan Kettering Cancer Center (MSK) researchers in the USA have identified…